Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C

Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C

Objective: The treatment of the chronic hepatitis C (HCV) with α-interferon is associated with thyroid dysfunction (TD). The aim of this study was to evaluate thyroid function outcome among patients with chronic HCV under treatment with conventional interferon (IFN) or peguilated interferon (PEG-IFN...

Full description

Bibliographic Details
Main Authors:	Maria Helena Postal Pavan, MSc, MD, Elizabeth João Pavin, PhD, Fernando Lopes Gonçales, Jr, PhD, Denise Engelbrecht Zantut Wittmann, PhD
Format:	Article
Language:	English
Published:	Elsevier 2011-09-01
Series:	Brazilian Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1413867011702264

Similar Items

Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C
by: Maria Helena Postal Pavan, et al.

Corrigendum in "Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C"

Corrigendum in "Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C"
Published: (2013-02-01)

Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3
by: Aline Gonzalez Vigani, et al.
Published: (2012-05-01)

Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3
by: Aline Gonzalez Vigani, et al.

Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
by: Luis Jesuino de Oliveira Andrade, PhD, et al.
Published: (2011-07-01)

Two cases of subungual myiasis in predisposed patients
by: Ui Hyeon Jo, MD, et al.
Published: (2021-08-01)

The Relationship between Predisposing Factors and Self-care Behaviors among Patients with Rheumatoid Arthritis
by: M Morowatisharifabad (Ph.D), et al.
Published: (2009-10-01)

Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C
by: Dorta Guridi Zaily, MD, PhD, MS, PM, et al.
Published: (2017-01-01)

Linn and C.DC. Reduce Oxidative Stress and Ameliorate -Induced Parasitemia and Cytokines in BALB/c Mice
by: Hope Onohuean MSc, PhD Fellow, et al.
Published: (2021-08-01)

Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
by: Aline Gonzalez Vigani, MD, PhD, et al.
Published: (2010-03-01)

An Association of Cryptococcus Neoformans/C. gattii Genotype and HIV Status in Asia: A Systematic Review
by: Popchai Ngamskulrungroj, M.D.,Ph.D., et al.
Published: (2019-03-01)

Pegylated interferon/ribavirin-associated sudden hearing loss in a patient with chronic hepatitis C in Brazil
by: Maria Cassia Jacintho Mendes-Corrêa, MD, PhD, et al.
Published: (2011-01-01)

Central Hypothyroidism due to Pituitary Iron Overload
by: Run Yu, MD, PhD
Published: (2021-09-01)

The protective role of folic acid on tratogenic effect of Carbamazepine in Balb/c mice
by: Afshar M (PhD), et al.
Published: (2010-09-01)

Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon
by: Sandro da Costa Ferreira, MD, et al.
Published: (2010-07-01)

Preclinical PET Neuroimaging of [C]Bexarotene
by: Benjamin H. Rotstein PhD, et al.
Published: (2016-08-01)

Hypothyroidism Could be a Potential Factor to Prolong Subcutaneous Nodules of Exenatide once Weekly: A Case Report
by: Ayako Ito, MD, et al.
Published: (2019-05-01)

Difficulties with interferon treatment in former intravenous drug users
by: Gábor Gazdag, MD, PhD, et al.
Published: (2011-03-01)

Cassia Abbreviata Enhances Glucose Uptake and Glucose Transporter 4 Translocation in C2C12 Mouse Skeletal Muscle Cells
by: F. D. Y. Kamga-Simo PhD, et al.
Published: (2021-03-01)

Laboratory Limitations of Excluding Hereditary Protein C Deficiency by Chromogenic Assay: Discrepancies of Phenotype and Genotype
by: Holger Seidel MD, et al.
Published: (2020-04-01)

Commentary on “A Microfluidic Platform to Design Crosslinked Hyaluronic Acid Nanoparticles (cHANPs) for Enhanced MRI”
by: Maria Russo PhD, et al.
Published: (2017-08-01)

IgE Reactivity to Common Cypress (C. Sempervirens) Pollen Extracts: Evidence for Novel Allergens
by: Youcef. Shahali, MSc, et al.
Published: (2010-01-01)

Radiation-Induced Hypothyroidism After Radical Intensity Modulated Radiation Therapy for Oropharyngeal Carcinoma
by: Mona Kamal, MD, PhD, et al.
Published: (2020-01-01)

Identification of T-cell epitopes on MPB51 antigen of Mycobacterium tuberculosis in BALB/c mice
by: AR.Rafiei (PhD), et al.
Published: (2005-04-01)

Jumonji: Welcome to the World of Interferon Signaling in Alcohol and HCV
by: Akshata Moghe, MD, PhD
Published: (2018-01-01)

Transient receptor potential cation channel subfamily C member 6 participates in functional regulation of vascular smooth muscle cells
by: Ljubica Matic, MSc, PhD
Published: (2020-01-01)

Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study
by: Dr. Romulus Breban, PhD, et al.
Published: (2014-09-01)

Severe Prolonged Hypothyroidism
by: Yonatan Yeshayahu MD, MHA, et al.
Published: (2015-03-01)

Pharmacokinetic Evaluation of [C]CEP-32496 in Nude Mice Bearing BRAF Mutation-Induced Melanomas
by: Cuiping Jiang MMSc, et al.
Published: (2018-09-01)

Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics
by: Simon Schroeder, MSc, et al.
Published: (2021-05-01)

Optimizing Implementation of Hepatitis C Birth-Cohort Screening and Treatment Strategies
by: Yuankun Li MS, et al.
Published: (2017-01-01)

High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib
by: Atsushi Osoegawa, MD, PhD, et al.
Published: (2021-07-01)

Natriuretic Peptide Receptor-C Protects Against Angiotensin II-Mediated Sinoatrial Node Disease in Mice
by: Martin Mackasey, BSc, et al.
Published: (2018-12-01)

The “Golden Hours” Algorithm For the Management of the Multisystem Inflammatory Syndrome in Children (MIS-C)
by: Sanaa Mahmoud MD, PhD, et al.
Published: (2021-01-01)

T-Cell Specificity Matters in IBD: Impaired IL10 Production Revealed by OmpC-Tetramers
by: Laura Cook, PhD, et al.
Published: (2020-01-01)

The Analgesic and Anti-Inflammatory Activity of in Balb/c Mice
by: Mahmoud Rafieian-kopaei PhD, et al.
Published: (2017-10-01)

Validation of the Proposed cN2 Subclassification in the Eighth Edition of the IASLC Staging System: A Prospective Phase II Multicenter Study
by: Jiro Abe, MD, et al.
Published: (2020-06-01)

Heterogeneity of Hepatitis C Virus Particles and Their Evolution During Infection
by: Agata Budkowska, PhD
Published: (2017-11-01)

Distribution of some Glycoconjugates in Notochord and axial vessels during early morphogenesis in Balb/C mouse embryos
by: M.M.Hasanzadeh-Tahery (M.Sc), et al.
Published: (2003-03-01)